Summaries & Associations of Study Results
TR-518 Triethanolamine
Target Organs and Levels of Evidence
NTP Technical Report Number 518
Produced from Chemtrack Database 06/18/03
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| TRIETHANOLAMINE 102-71-6 |
05/22/03 | INTERMEDIATE IN MANUF. SURFACTANTS, TEXTILE SPECIALTIES, WAXES, POLISHES, HERBICIDES, PETROLEUM DEMULSIFIERS,TOILET GOODS, CEMENT ADDITIVES, CUTTING OILS, IN MAKING MINERAL & VEG. OIL EMULSIONS, SOLVENT, PHARMACEUTIC AID (ALKALIZER) (MERCK 1989). | Topical Application MM: 0, 200, 630, OR 2000 MG/KG; FM: 0, 100, 300, OR 1000 MG/KG | Battelle Columbus Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MM: EQUIVOCAL EVIDENCE | ||||
| MAY HAVE BEEN RELATED: | LIVER: HEMANGIOSARCOMA 1/50 0/50 6/50 1/50 | |||
| NON-NEOPLASTIC LESIONS: | LIVER: EOSINOPHILIC FOCUS | |||
| SKIN: (EPIDERMAL) HYPERPLASIA; SUPPURATIVE INFLAMMATION; ULCER; (DERMAL) CHRONIC INFLAMMATION | ||||
| FM: SOME EVIDENCE | LIVER: ADENOMA 9/50 18/50 20/50 33/50 COMBINED 12/50 23/50 24/50 34/50 | |||
| NON-NEOPLASTIC LESIONS: | LIVER: EOSINOPHILIC FOCUS | |||
| SKIN: (EPIDERMAL) HYPERPLASIA; SUPPURATIVE INFLAMMATION; ULCER; (DERMAL) CHRONIC INFLAMMATION | ||||
Web page last updated on February 10, 2006
